XML 20 R8.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Operating Activities    
Net income $ 11,702 $ 17,992
Adjustments to reconcile net income to net cash provided by operating activities:    
Accretion and amortization 117 (1,922)
Provision for loan losses 539 888
Depreciation of premises and equipment 1,567 1,511
Deferred income tax expense 830 964
Net periodic employee benefit cost 129 200
Realized investment securities gains 0 (14)
Stock-compensation expense 755 740
Increase in value of bank-owned life insurance (760) (764)
Loans originated for sale (2,809) (4,184)
Proceeds from the sale of loans originated for sale 3,107 3,637
Gain on sale of loans (58) (58)
Gain on sale of insurance division 0 (11,084)
Change in accrued interest receivable (1,085) (926)
Change in other assets (10,630) (1,824)
Change in other liabilities 11,432 8,343
Net Cash Provided by Operating Activities 14,836 13,499
Investing Activities    
Proceeds from sales of securities available-for-sale 35 0
Proceeds from maturities and calls of securities available-for-sale 18,078 16,172
Proceeds from maturities and calls of securities held-to-maturity 2,332 3,336
Purchases of securities available-for-sale (4,289) (34,857)
Net (increase) decrease in loans (14,668) 21,622
Purchases of premises and equipment (610) (472)
Disposals of premises and equipment 341 0
Proceeds from sale of insurance division 0 15,250
Net Cash Provided by Investing Activities 1,219 21,051
Financing Activities    
Net increase in non-interest-bearing deposits 45,450 6,131
Net increase in interest-bearing deposits 57,994 63,633
Net increase (decrease) in short-term borrowings 1,845 (2,343)
Purchases of treasury stock (9,925) 0
Proceeds from exercise of stock options, net of tax benefit 0 975
Dividends paid (6,367) (6,064)
Net Cash Provided by Financing Activities 88,997 62,332
Increase in Cash and Cash Equivalents 105,052 96,882
Cash and cash equivalents at beginning of period 70,113 148,228
Cash and Cash Equivalents at End of Period $ 175,165 $ 245,110